Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated…

Overview of attention for article published in Annals of Neurology, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#24 of 6,674)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 57 news outlets
blogs: 4 blogs
twitter: 24 X users

wikipedia: 1 Wikipedia page
reddit: 1 Redditor

Readers on

mendeley: 139 Mendeley

So far, Altmetric has seen 88 news stories from 57 outlets.

Star USC scientist faces scrutiny — retracted papers and a paused drug trial

The News-Herald, 25 May 2024

Corinne Purtill | Los Angeles Times (TNS) LOS ANGELES — Late last year, a group of whistle-blowers submitted a report to the…

Star USC scientist faces scrutiny — retracted papers and a paused drug trial

Orlando Sentinel, 25 May 2024

Corinne Purtill | Los Angeles Times (TNS) LOS ANGELES Late last year, a group of whistle-blowers submitted a report to the…

News story from Hartford Courant on Saturday 25 May 2024

Hartford Courant, 25 May 2024

Star USC scientist faces scrutiny — retracted papers and a paused drug trial

The Record, 25 May 2024

Corinne Purtill | Los Angeles Times (TNS) LOS ANGELES — Late last year, a group of whistle-blowers submitted a report to the…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 84 additional news stories.